PMC:7402624 / 31861-31983
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T281 | 23-27 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T282 | 73-76 | Body_part | denotes | IgD | http://purl.org/sig/ont/fma/fma62876 |
| T283 | 91-96 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1189 | 63-68 | Gene | denotes | CXCR5 | Gene:643 |
| 1207 | 13-20 | Species | denotes | patient | Tax:9606 |
| 1229 | 4-12 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1230 | 102-104 | Disease | denotes | HD | MESH:D006816 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T255 | 4-12 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T256 | 102-104 | Disease | denotes | HD | http://purl.obolibrary.org/obo/MONDO_0007739 |
| T257 | 109-111 | Disease | denotes | RD | http://purl.obolibrary.org/obo/MONDO_0009973 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T539 | 21-27 | http://purl.obolibrary.org/obo/CL_0000236 | denotes | B cell |
| T540 | 89-96 | http://purl.obolibrary.org/obo/CL_0000236 | denotes | B cells |
| T541 | 109-111 | http://purl.obolibrary.org/obo/CLO_0008770 | denotes | RD |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T233 | 102-104 | Chemical | denotes | HD | http://purl.obolibrary.org/obo/CHEBI_73925 |
| T234 | 109-111 | Chemical | denotes | RD | http://purl.obolibrary.org/obo/CHEBI_73812 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T184 | 0-122 | Sentence | denotes | The COVID-19 patient B cell phenotype was dominated by loss of CXCR5 and IgD compared to B cells from HD and RD (Fig. 4J). |